6-K//Foreign company update
LakeShore Biopharma Co., Ltd. 6-K
Accession 0001213900-25-105603
$LSBCFCIK 0001946399other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 7:13 AM ET
Size
509.9 KB
Accession
0001213900-25-105603
Documents
- 6-Kea0263592-6k_lakeshore.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-99.1ea026359201ex99-1_lakeshore.htm
PRESS RELEASE - LAKESHORE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT FOR GOING-PRIVATE TRANSACTION
- EX-99.2ea026359201ex99-2_lakeshore.htm
AGREEMENT AND PLAN OF MERGER, DATED NOVEMBER 4, 2025, BY AND AMONG LAKESHORE BIOPHARMA CO., LTD, OCEANPINE SKYLINE INC. AND OCEANPINE MERGER SUB INC
Issuer
LakeShore Biopharma Co., Ltd.
CIK 0001946399
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001946399
Filing Metadata
- Form type
- 6-K
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 7:13 AM ET
- Size
- 509.9 KB